UC148
6-羟基氯唑沙宗
≥98% (HPLC), solid, chlorzoxazone metabolite
别名:
5-Chloro-6-hydroxybenzoxazone, 5-氯-6-羟基-2(3H)-苯并噁唑酮
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C7H4ClNO3
化学文摘社编号:
分子量:
185.56
UNSPSC Code:
12161501
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Application
6-羟基氯唑沙宗已用于基于 HPLC 的氯唑沙宗代谢分析 。
6-羟基氯唑沙宗已被用作：作为参考标准品，在重组人酶筛选中监测底物消耗或通过细胞色素 P450 家族 2 亚家族 E 成员 1 (CYP2E1) 所形成的 6-羟基氯唑沙宗。6-羟基氯唑沙宗已被用于基于高效液相色谱 (HPLC) 的氯唑沙宗代谢测定。
氯唑沙宗的 CYP2E1 & 1A2 代谢物。
Biochem/physiol Actions
6-羟基氯唑沙宗是一种新型氯唑沙宗代谢物。它是由细胞色素 P450 家族 2 亚家族 E 成员 1 (CYP2E1) 酶将氯唑沙宗羟基化形成的。确定 6-羟基氯唑沙宗的形成和清除被用作表征 CYP2E1 代谢活性的一种可靠标记。
Packaging
无底玻璃瓶。内含物装在插入的融合锥内。
Preparation Note
6-羟基氯唑沙宗可溶于甲醇。
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
In vitro CYP/FMO Reaction Phenotyping
Optimization in Drug Discovery: In Vitro Methods, 137-169 (2014)
Drug Metabolism in Chronic Kidney Disease
Chronic Renal Disease, 1035-1051 (2020)
C B Eap et al.
Journal of chromatography. B, Biomedical sciences and applications, 705(1), 139-144 (1998-03-14)
A gas chromatographic-mass spectrometric method is presented which allows the determination of chlorzoxazone and 6-hydroxychlorzoxazone after derivatization with the reagent N-tert.-butyldimethylsilyl-N-methyltrifluoroacetamide. No interference was observed from endogenous compounds following the extraction of plasma samples from six different human subjects. The
Eva González-Jasso et al.
Toxicology letters, 144(1), 55-67 (2003-08-16)
The inducibility of CYP2E1 was investigated in liver and peripheral lymphocytes of rats treated with benzene (0-10 mmol/kg body weight (bw), daily for 3 days, i.p., or 0 and 5 mmol/kg bw, daily for 14 days, i.p.) or toluene (0
Hye W Baek et al.
Journal of pharmaceutical sciences, 95(11), 2452-2462 (2006-08-04)
Pharmacokinetic parameters of chlorzoxazone (CZX) and its main metabolite, 6-hydroxychlorzoxazone (OH-CZX), were compared after intravenous (20 mg/kg) and oral (50 mg/kg) administration of CZX in rat model of diabetes induced by alloxan (DMIA) or streptozotocin (DMIS), and their respective control
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持